Literature DB >> 9398000

Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.

L J Meng1, H Reyes, M Axelson, J Palma, I Hernandez, J Ribalta, J Sjövall.   

Abstract

The concentrations in serum of sulfated metabolites of progesterone are known to be elevated in patients with intrahepatic cholestasis of pregnancy (ICP). The profiles of these metabolites and conjugated bile acids were analyzed in serum from 11 patients with ICP before and during administration of ursodeoxycholic acid (UDCA) (8 patients) or placebo (3 patients). The clinical condition of 7 of the patients given UDCA improved markedly, and 1 patient given placebo had a spontaneous remission of the disease. The total concentration of conjugated bile acids in the 11 patients was 25 +/- 6 micromol/L (mean +/- SEM) and decreased to 6.3 +/- 3.5 micromol/L in the 7 patients responding to treatment with UDCA. The level of 7alpha-hydroxy-4-cholesten-3-one was significantly lower (7.2 +/- 2.2 ng/mL) in patients with ICP than in healthy pregnancy (18 +/- 4.6 ng/mL) (P < .05). The concentrations of 5alpha-pregnane-3alpha,20alpha-diol mono- and disulfates decreased by 52% +/- 7.9% and 68% +/- 5.5%, respectively, in the patients responding to treatment. Similar decreases were observed for the mono- and disulfates of 5alpha-pregnane-3alpha,20alpha,21-triol and 5beta-pregnane-3alpha,20alpha-diol. The disulfate of 5alpha-pregnane-3beta,20alpha-diol showed a smaller decrease, while glucuronidated steroids were not affected. The 3alpha-/3beta-hydroxysteroid ratio and di-/monosulfate ratio decreased significantly during UDCA. The magnitudes of the changes of bile acid and steroid concentrations during UDCA were not correlated to each other. The results suggest that UDCA stimulates the biliary excretion of steroids with a 3alpha-sulfoxy group and disulfates. This effect seems to be independent of the effect on bile acid excretion, indicating the use of different transport proteins. The possibility of an effect of UDCA on the formation of the steroid sulfates cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398000     DOI: 10.1002/hep.510260627

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 3.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

4.  Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies.

Authors:  U Pecks; W Rath; N Kleine-Eggebrecht; N Maass; F Voigt; T W Goecke; M G Mohaupt; G Escher
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

5.  Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Authors:  Kathleen G Barrett; Hailin Fang; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2015-05-06       Impact factor: 3.922

6.  Role of sex hormones in the modulation of cholangiocyte function.

Authors:  Romina Mancinelli; Paolo Onori; Sharon Demorrow; Heather Francis; Shannon Glaser; Antonio Franchitto; Guido Carpino; Gianfranco Alpini; Eugenio Gaudio
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

7.  Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.

Authors:  C M Rodrigues; J J Marín; D Brites
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 8.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

9.  Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.

Authors:  Maria C Estiú; Maria J Monte; Laura Rivas; Maria Moirón; Laura Gomez-Rodriguez; Tomas Rodriguez-Bravo; Jose J G Marin; Rocio I R Macias
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

10.  Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy.

Authors:  Jurate Kondrackiene; Ulrich Beuers; Rimantas Zalinkevicius; Horst-Dietmar Tauschel; Vladas Gintautas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.